Contracts › HT942525CE052
HT942525CE052: Phase Ii Sbir- Rapid, Automated, Multiplexed Omics Platform
Awarded to Emergingdx Inc by Defense Health Agency.
$1.3Mobligated
$1.3Mpotential value
25 January 2028current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | HT942525CE052 |
|---|---|
| Awardee | Emergingdx Inc |
| Awarding agency | Defense Health Agency |
| Awarding office | ARMY MED RES ACQ ACTIVITY |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN11 Health R&D Services; Health Care Services; Basic Research |
| Place of performance | MA |
| Offers received | 1 |
| Period of performance | 26 September 2025 to 25 January 2028 |
| Potential end | 25 January 2028 |
| Estimated recompete solicitation | ~Q3 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record